INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 46m ago
HOUSE PTR5m ago
SEC 13F5m ago
ROBINHOOD CHAIN5m ago
Corporate insider
MJ

Mercier Johanna

Chief Commercial OfficerCIK 0001782135

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 3
Max Insider Score21
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
7
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$469K
3,000 sh
Oct 15, 2026Oct 16, 2026
traded Oct 15, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NEUROCRINE BIOSCIENCES INCDirector · May 29, 2026
  • Insider ofevidence
    GILEAD SCIENCES, INC.Chief Commercial Officer · Dec 11, 2025
9
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M
—
2,797 sh
Sep 10, 2026
Sep 11, 2026
traded Sep 10, 2026
+1d
SEC FORM 4

Evidence

5
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
2,797 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

8
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Tax withholding
F$195K
1,347 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

9
MJ
Mercier JohannaDirector
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
2,567 sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

12
MJ
Mercier JohannaChief Comm & Corp Aff Officer
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$423K
3,000 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC FORM 4

Evidence

21
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$373K
3,000 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

12
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Tax withholding
F$220K
1,814 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence

9
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
3,842 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence

13
MJ
Mercier JohannaChief Commercial Officer
GILDGILEAD SCIENCES, INC.
Option exercise
M—
3,842 sh
Dec 10, 2025Dec 11, 2025
traded Dec 10, 2025
+1dSEC FORM 4

Evidence